Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00509600 · ADVERSE EVENTS

Adverse events

Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia · Source last updated 2012-08-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.

Collection time frame
Study period 4 years and 10 months. Only patient registered on study for two (2) months.
Other-event reporting threshold
5%
Participants affected / participants at risk, as reported
Safety groupSerious eventsOther eventsDeaths
Etanercept

0.8 mg/kg subcutaneously weekly for 90 days

1 / 10 / 1Not reported / Not reported

Group identifiers: EG000: Etanercept

Serious adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

  1. assessment Type
    SYSTEMATIC_ASSESSMENT
    notes
    Grade 3 Non-hematological Toxicity.
    organ System
    General disorders
    source Vocabulary
    CTCAE (3.0)
    stats
    1. group Id
      EG000
      num Affected
      1
      num At Risk
      1
      num Events
      1
    term
    Toxicity

Other reported adverse events

Event terms and counts are source-reported; expand to read more. A reporting threshold may omit less frequent events.

    Complete source fields
    event Groups
    1. description
      0.8 mg/kg subcutaneously weekly for 90 days
      id
      EG000
      other Num Affected
      0
      other Num At Risk
      1
      serious Num Affected
      1
      serious Num At Risk
      1
      title
      Etanercept
    frequency Threshold
    5
    serious Events
    1. assessment Type
      SYSTEMATIC_ASSESSMENT
      notes
      Grade 3 Non-hematological Toxicity.
      organ System
      General disorders
      source Vocabulary
      CTCAE (3.0)
      stats
      1. group Id
        EG000
        num Affected
        1
        num At Risk
        1
        num Events
        1
      term
      Toxicity
    time Frame
    Study period 4 years and 10 months. Only patient registered on study for two (2) months.

    Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

    Preserved source evidence · Not medical advice